{"id":"https://openalex.org/W3132367902","doi":"https://doi.org/10.1158/1538-7445.sabcs20-ot-13-04","title":"Abstract OT-13-04: Solti-1716. Targeting non-Luminal disease by PAM50 with pembrolizumab + paclitaxel in Hormone Receptor-positive/HER2-negative advanced/metastatic breast cancer patients who have progressed on or after CDK 4/6 inhibitor treatment (TATEN trial)","display_name":"Abstract OT-13-04: Solti-1716. Targeting non-Luminal disease by PAM50 with pembrolizumab + paclitaxel in Hormone Receptor-positive/HER2-negative advanced/metastatic breast cancer patients who have progressed on or after CDK 4/6 inhibitor treatment (TATEN trial)","publication_year":2021,"publication_date":"2021-02-15","ids":{"openalex":"https://openalex.org/W3132367902","doi":"https://doi.org/10.1158/1538-7445.sabcs20-ot-13-04","mag":"3132367902"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs20-ot-13-04","doi":"https://doi.org/10.1158/1538-7445.sabcs20-ot-13-04","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs20-ot-13-04","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020050040","display_name":"Eva M. Ciruelos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101691","display_name":"Hospital Universitario 12 De Octubre","ror":"https://ror.org/00qyh5r35","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210101691","https://openalex.org/I4210139293"]},{"id":"https://openalex.org/I4210133410","display_name":"Solti","ror":"https://ror.org/03xb7kp74","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210133410"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Eva Ciruelos","raw_affiliation_strings":["1Hospital Universitario 12 de Octubre/SOLTI Breast Cancer Research Group, Madrid/Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Hospital Universitario 12 de Octubre/SOLTI Breast Cancer Research Group, Madrid/Barcelona, Spain","institution_ids":["https://openalex.org/I4210101691","https://openalex.org/I4210133410"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043895722","display_name":"Tom\u00e1s Pascual","orcid":"https://orcid.org/0000-0001-8431-3183","observed_orcids":["https://orcid.org/0000-0001-8431-3183"]},"institutions":[{"id":"https://openalex.org/I4210115097","display_name":"Hospital Cl\u00ednic de Barcelona","ror":"https://ror.org/02a2kzf50","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210115097"]},{"id":"https://openalex.org/I4210133410","display_name":"Solti","ror":"https://ror.org/03xb7kp74","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210133410"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Tom\u00e1s Pascual","raw_affiliation_strings":["2Hospital Clinic de Barcelona/SOLTI Breast Cancer Research Group, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Hospital Clinic de Barcelona/SOLTI Breast Cancer Research Group, Barcelona, Spain","institution_ids":["https://openalex.org/I4210115097","https://openalex.org/I4210133410"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077175788","display_name":"N\u00faria Chic","orcid":"https://orcid.org/0000-0001-9736-6276","observed_orcids":["https://orcid.org/0000-0001-9736-6276"]},"institutions":[{"id":"https://openalex.org/I4210115097","display_name":"Hospital Cl\u00ednic de Barcelona","ror":"https://ror.org/02a2kzf50","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210115097"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Nuria Chic","raw_affiliation_strings":["3Hospital Clinic de Barcelona, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Hospital Clinic de Barcelona, Barcelona, Spain","institution_ids":["https://openalex.org/I4210115097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089285482","display_name":"Montserrat Mu\u00f1oz-Mateu","orcid":"https://orcid.org/0000-0001-7772-1437","observed_orcids":["https://orcid.org/0000-0001-7772-1437"]},"institutions":[{"id":"https://openalex.org/I4210115097","display_name":"Hospital Cl\u00ednic de Barcelona","ror":"https://ror.org/02a2kzf50","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210115097"]},{"id":"https://openalex.org/I4210133410","display_name":"Solti","ror":"https://ror.org/03xb7kp74","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210133410"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Montserrat Mu\u00f1oz","raw_affiliation_strings":["2Hospital Clinic de Barcelona/SOLTI Breast Cancer Research Group, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Hospital Clinic de Barcelona/SOLTI Breast Cancer Research Group, Barcelona, Spain","institution_ids":["https://openalex.org/I4210115097","https://openalex.org/I4210133410"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018922989","display_name":"Bego\u00f1a Bermejo","orcid":"https://orcid.org/0000-0001-7773-5994","observed_orcids":["https://orcid.org/0000-0001-7773-5994"]},"institutions":[{"id":"https://openalex.org/I4210094406","display_name":"Hospital Cl\u00ednico Universitario de Valencia","ror":"https://ror.org/00hpnj894","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210094406"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Bego\u00f1a Bermejo","raw_affiliation_strings":["4Hospital Cl\u00ednico Universitario de Valencia, Valencia, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Hospital Cl\u00ednico Universitario de Valencia, Valencia, Spain","institution_ids":["https://openalex.org/I4210094406"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113600166","display_name":"Juan Antonio Virizuela","orcid":"https://orcid.org/0009-0007-2795-1673","observed_orcids":["https://orcid.org/0009-0007-2795-1673","https://orcid.org/0009-0005-7337-8615"]},"institutions":[{"id":"https://openalex.org/I4210095067","display_name":"Hospital Quir\u00f3nsalud Sagrado Coraz\u00f3n","ror":"https://ror.org/00p8vgm81","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210095067"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Juan Antonio Virizuela","raw_affiliation_strings":["5Hospital Quir\u00f3n Sagrado Coraz\u00f3n, Sevilla, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Hospital Quir\u00f3n Sagrado Coraz\u00f3n, Sevilla, Spain","institution_ids":["https://openalex.org/I4210095067"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053983312","display_name":"Mafalda Oliveira","orcid":"https://orcid.org/0000-0001-9152-8799","observed_orcids":["https://orcid.org/0000-0001-9152-8799"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4210133410","display_name":"Solti","ror":"https://ror.org/03xb7kp74","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210133410"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Mafalda Oliveira","raw_affiliation_strings":["6Vall d'Hebron University Hospital/SOLTI Breast Cancer Research Group/Vall d\u2019Hebron Institute of Oncology (VHIO), Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Vall d'Hebron University Hospital/SOLTI Breast Cancer Research Group/Vall d\u2019Hebron Institute of Oncology (VHIO), Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641","https://openalex.org/I4210133410","https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110962840","display_name":"Silvia V\u00e1zquez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210107147","display_name":"Institut Catal\u00e0 d'Oncologia","ror":"https://ror.org/01j1eb875","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210107147"]},{"id":"https://openalex.org/I4210143012","display_name":"Duran i Reynals Hospital","ror":"https://ror.org/03qwghy04","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210143012"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Silvia V\u00e1zquez","raw_affiliation_strings":["7Hospital Duran i Reynals-Institut Catal\u00e0 d\u2019Oncologia, Hospitalet de Llobregat, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Hospital Duran i Reynals-Institut Catal\u00e0 d\u2019Oncologia, Hospitalet de Llobregat, Barcelona, Spain","institution_ids":["https://openalex.org/I4210107147","https://openalex.org/I4210143012"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112899140","display_name":"Salvador Blanch","orcid":"https://orcid.org/0009-0008-9553-2179","observed_orcids":["https://orcid.org/0009-0008-9553-2179"]},"institutions":[{"id":"https://openalex.org/I4210103093","display_name":"Fundaci\u00f3n Instituto Valenciano de Oncolog\u00eda","ror":"https://ror.org/01fh9k283","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210103093"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Salvador Blanch","raw_affiliation_strings":["8Instituto Valenciano de Oncolog\u00eda, Valencia, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8Instituto Valenciano de Oncolog\u00eda, Valencia, Spain","institution_ids":["https://openalex.org/I4210103093"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070297345","display_name":"Laia Par\u00e9","orcid":"https://orcid.org/0000-0002-4904-558X","observed_orcids":["https://orcid.org/0000-0002-4904-558X"]},"institutions":[{"id":"https://openalex.org/I4210133410","display_name":"Solti","ror":"https://ror.org/03xb7kp74","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210133410"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Laia Par\u00e9","raw_affiliation_strings":["9SOLTI Breast Cancer Research Group, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9SOLTI Breast Cancer Research Group, Barcelona, Spain","institution_ids":["https://openalex.org/I4210133410"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075332457","display_name":"Fernando Salvador","orcid":"https://orcid.org/0000-0002-5442-1754","observed_orcids":["https://orcid.org/0000-0002-5442-1754"]},"institutions":[{"id":"https://openalex.org/I4210133410","display_name":"Solti","ror":"https://ror.org/03xb7kp74","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210133410"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Fernando Salvador","raw_affiliation_strings":["9SOLTI Breast Cancer Research Group, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9SOLTI Breast Cancer Research Group, Barcelona, Spain","institution_ids":["https://openalex.org/I4210133410"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080122151","display_name":"Patricia Villagrasa","orcid":"https://orcid.org/0000-0002-8662-3641","observed_orcids":["https://orcid.org/0000-0002-8662-3641"]},"institutions":[{"id":"https://openalex.org/I4210133410","display_name":"Solti","ror":"https://ror.org/03xb7kp74","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210133410"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Patricia Villagrasa","raw_affiliation_strings":["9SOLTI Breast Cancer Research Group, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9SOLTI Breast Cancer Research Group, Barcelona, Spain","institution_ids":["https://openalex.org/I4210133410"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089513581","display_name":"Aleix Prat","orcid":"https://orcid.org/0000-0003-2377-540X","observed_orcids":["https://orcid.org/0000-0003-2377-540X"]},"institutions":[{"id":"https://openalex.org/I4210115097","display_name":"Hospital Cl\u00ednic de Barcelona","ror":"https://ror.org/02a2kzf50","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210115097"]},{"id":"https://openalex.org/I4210133410","display_name":"Solti","ror":"https://ror.org/03xb7kp74","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210133410"]},{"id":"https://openalex.org/I4210160192","display_name":"Consorci Institut D'Investigacions Biomediques August Pi I Sunyer","ror":"https://ror.org/054vayn55","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210115097","https://openalex.org/I4210160192","https://openalex.org/I4387153040","https://openalex.org/I4403928279"]},{"id":"https://openalex.org/I71999127","display_name":"Universitat de Barcelona","ror":"https://ror.org/021018s57","country_code":"ES","type":"education","lineage":["https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Aleix Prat","raw_affiliation_strings":["10Hospital Clinic de Barcelona/SOLTI Breast Cancer Research Group/August Pi i Sunyer Biomedical Research Institute (IDIBAPS)/Medicine Department, University of Barcelona, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10Hospital Clinic de Barcelona/SOLTI Breast Cancer Research Group/August Pi i Sunyer Biomedical Research Institute (IDIBAPS)/Medicine Department, University of Barcelona, Barcelona, Spain","institution_ids":["https://openalex.org/I4210115097","https://openalex.org/I4210133410","https://openalex.org/I4210160192","https://openalex.org/I71999127"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":12,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"81","issue":"4_Supplement","first_page":"OT","last_page":"13"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9330999851226807,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9330999851226807,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.06610000133514404,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pam50-subtypes","display_name":"PAM50 molecular subtypes","score":0.8399999737739563},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9670000076293945},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.996999979019165},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.6129999756813049},{"id":"https://openalex.org/keywords/cdk4-6-inhibitor-resistance","display_name":"CDK4/6 inhibitor resistance","score":0.7829999923706055},{"id":"https://openalex.org/keywords/hr-her2-breast-cancer","display_name":"hormone receptor-positive HER2-negative breast cancer","score":0.8339999914169312},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.8899999856948853},{"id":"https://openalex.org/keywords/her2-enriched-breast-cancer","display_name":"HER2-enriched breast cancer","score":0.7360000014305115},{"id":"https://openalex.org/keywords/basal-like-subtype","display_name":"basal-like subtype","score":0.9440000057220459}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8350932002067566},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.8316953182220459},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.7460851669311523},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.72022545337677},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7020018100738525},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6545066237449646},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.522611677646637},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.44409409165382385},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.41070666909217834},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3521478474140167}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs20-ot-13-04","doi":"https://doi.org/10.1158/1538-7445.sabcs20-ot-13-04","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs20-ot-13-04","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4220728021","https://openalex.org/W4322775203","https://openalex.org/W4396596449","https://openalex.org/W7125376313","https://openalex.org/W4406063101","https://openalex.org/W4220656953","https://openalex.org/W4322771955","https://openalex.org/W3133304477","https://openalex.org/W4245285033","https://openalex.org/W3031572863"],"abstract_inverted_index":{"Abstract":[0],"Background.":[1],"Patients":[2,488],"with":[3,14,18,112,123,203,207,211,228,284,420,545],"metastatic":[4,151,184,215,239,257],"Hormone":[5,550],"Receptor-positive/HER2-negative":[6,551],"(HR+/HER2-)":[7],"breast":[8,154,553],"cancer":[9,155,554],"(BC)":[10],"are":[11,166,247,336,381,452],"usually":[12],"treated":[13],"CDK4/6":[15,29,84,230],"inhibitors":[16,30,165],"combined":[17],"endocrine":[19,32,233],"therapy":[20,33,227,234],"(ET)":[21],"as":[22,102,408,410],"first":[23,345],"line":[24],"treatment.":[25,73],"The":[26,86,302,316,370],"addition":[27],"of":[28,56,98,136,162,179,274,294,305,366,400,415,433,436,450,457,482,571],"to":[31,71,83,130,175,309,313,328,340,351,404,411,467,478,484],"has":[34,146],"demonstrated":[35],"improved":[36],"progression":[37,223],"free":[38],"survival":[39,49],"(PFS),":[40],"overall":[41,48],"response":[42,401,405,483],"rate":[43,396],"(ORR)":[44],"and":[45,65,105,116,132,139,156,181,324,355,424,448,455,472,477],"more":[46,128,334,379],"recently":[47],"(OS).":[50],"However,":[51],"there":[52,75],"is":[53,76,192,259,308,504],"a":[54,103,229,320,363],"20%":[55],"patients":[57,81,111,210,262,342,358,555],"who":[58,67,219,556],"do":[59],"not":[60],"benefit":[61,395,417],"from":[62],"these":[63],"drugs":[64],"those":[66,122],"respond":[68],"eventually":[69],"progress":[70],"the":[72,90,95,160,177,236,306,344,347,352,413,458,572],"Notably,":[74],"no":[77],"standard":[78],"treatment":[79,202,451,565],"for":[80,149,252,362],"progressing":[82],"inhibitors.":[85],"information":[87],"provided":[88],"by":[89,507,543],"intrinsic":[91],"subtypes":[92,114],"(PAM50)":[93],"highlight":[94],"potential":[96],"value":[97],"BC":[99,170,218,258],"molecular":[100],"classification":[101],"prognosis":[104,120],"predictive":[106,480],"marker.":[107],"Within":[108],"HR+/HER2-":[109,169,217],"disease,":[110],"non-luminal":[113,187,216],"(HER2-enriched":[115],"Basal-like)":[117],"present":[118],"poorer":[119],"than":[121],"luminal":[124],"subtypes,":[125],"may":[126,359],"be":[127,360,374,386,462,490],"sensitive":[129],"chemotherapy,":[131],"have":[133,557],"higher":[134],"expression":[135,423],"immune-related":[137],"genes":[138],"tumor":[140],"infiltrating":[141],"lymphocytes":[142],"(TILs).":[143],"Recently,":[144],"immunotherapy":[145],"been":[147],"approved":[148],"treating":[150],"triple":[152],"negative":[153],"several":[157],"trials":[158],"evaluating":[159,201],"action":[161],"immune":[163],"checkpoint":[164],"ongoing,":[167],"including":[168],"patients.":[171,330,369],"TATEN":[172,191],"study":[173,200,307,317,503],"aims":[174],"evaluate":[176,310],"combination":[178,206,283,459],"pembrolizumab":[180,204,265,434,485,546],"chemotherapy":[182,251],"in":[183,205,209,235,279,282,338,343,428,492,495,499,549],"HR+/HER2-,":[185],"PAM50":[186,544],"BC.":[188],"Study":[189],"design.":[190],"an":[193],"open-label,":[194],"single":[195],"arm,":[196],"multicenter":[197],"phase":[198],"II":[199],"paclitaxel":[208,285,548],"locally":[212,254],"advanced":[213,255],"or":[214,222,256,333,378,560],"had":[220],"recurrence":[221],"while":[224],"receiving":[225],"previous":[226],"inhibitor":[231,564],"plus":[232,486],"adjuvant":[237],"and/or":[238],"setting.":[240],"Tumor":[241,383],"samples":[242,438],"collected":[243],"during":[244],"advanced/metastatic":[245,552],"disease":[246,542],"mandatory.":[248],"No":[249],"prior":[250],"inoperable":[253],"permitted.":[260],"Eligible":[261],"will":[263,318,325,349,373,385,460,489],"receive":[264],"200":[266],"mg":[267],"every":[268,388],"3":[269],"weeks":[270],"(on":[271],"day":[272],"1":[273,431,441,447],"each":[275,295],"21-day":[276,296],"cycle,":[277],"beginning":[278,298],"Cycle":[280,440,444],"1)":[281],"80":[286],"mg/m2":[287],"administered":[288],"at":[289,299,439],"days":[290],"1,":[291,443],"8,":[292],"15":[293,341],"cycle":[297,300,432],"2.":[301],"primary":[303],"endpoint":[304],"ORR":[311],"according":[312],"RECIST":[314],"V1.1.":[315],"use":[319],"Simon\u2019s":[321],"2-stage":[322],"design":[323],"include":[326,393,466],"up":[327,339],"46":[329,367],"If":[331],"6":[332],"responses":[335,380],"observed":[337],"stage,":[346],"trial":[348],"continue":[350],"second":[353],"stage":[354],"31":[356],"additional":[357],"evaluated":[361],"maximum":[364],"total":[365],"evaluable":[368],"null":[371],"hypothesis":[372],"rejected":[375],"if":[376],"19":[377],"observed.":[382],"assessments":[384],"performed":[387],"9":[389],"weeks.":[390],"Secondary":[391],"endpoints":[392],"clinical":[394,416],"(CBR),":[397],"PFS,":[398,470],"duration":[399],"(DoR),":[402],"time":[403],"(TtR),":[406],"OS,":[407],"well":[409],"assess":[412],"correlation":[414],"(ORR,":[418],"PFS)":[419],"PD1":[421],"mRNA":[422],"early":[425],"dynamic":[426],"changes":[427],"ctDNA":[429],"after":[430,561],"(collection":[435],"blood":[437],"Day":[442,446],"2":[445],"end":[449],"mandatory).":[453],"Safety":[454],"tolerability":[456],"also":[461],"assessed.":[463],"Exploratory":[464],"objectives":[465],"determine":[468],"ORR,":[469],"DoR":[471],"TtR":[473],"based":[474],"on":[475,559],"iRECIST":[476],"identify":[479],"biomarkers":[481],"paclitaxel.":[487],"enrolled":[491],"7":[493],"sites":[494],"Spain.":[496],"Recruitment":[497],"started":[498],"July":[500],"2020.":[501],"This":[502],"financially":[505],"supported":[506],"MSD.":[508],"NCT04251169.":[509],"Citation":[510],"Format:":[511],"Eva":[512],"Ciruelos,":[513],"Tom\u00e1s":[514],"Pascual,":[515],"Nuria":[516],"Chic,":[517],"Montserrat":[518],"Mu\u00f1oz,":[519],"Bego\u00f1a":[520],"Bermejo,":[521],"Juan":[522],"Antonio":[523,575],"Virizuela,":[524],"Mafalda":[525],"Oliveira,":[526],"Silvia":[527],"V\u00e1zquez,":[528],"Salvador":[529],"Blanch,":[530],"Laia":[531],"Par\u00e9,":[532],"Fernando":[533],"Salvador,":[534],"Patricia":[535],"Villagrasa,":[536],"Aleix":[537],"Prat.":[538],"Solti-1716.":[539],"Targeting":[540],"non-Luminal":[541],"+":[547],"progressed":[558],"CDK":[562],"4/6":[563],"(TATEN":[566],"trial)":[567],"[abstract].":[568],"In:":[569],"Proceedings":[570],"2020":[573,580],"San":[574,583],"Breast":[576],"Cancer":[577,589],"Virtual":[578],"Symposium;":[579],"Dec":[581],"8-11;":[582],"Antonio,":[584],"TX.":[585],"Philadelphia":[586],"(PA):":[587],"AACR;":[588],"Res":[590],"2021;81(4":[591],"Suppl):Abstract":[592],"nr":[593],"OT-13-04.":[594]},"counts_by_year":[{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2021-03-01T00:00:00"}